JPMorgan Chase & Co. set a €55.00 ($63.95) price target on Lanxess (ETR:LXS) in a research note issued to investors on Thursday. The firm currently has a buy rating on the stock.
Several other research firms also recently weighed in on LXS. Kepler Capital Markets set a €86.00 ($100.00) price target on shares of Lanxess and gave the stock a buy rating in a research note on Monday, November 12th. Goldman Sachs Group set a €67.00 ($77.91) price target on shares of Lanxess and gave the stock a buy rating in a research note on Tuesday, November 27th. UBS Group set a €78.00 ($90.70) price target on shares of Lanxess and gave the stock a buy rating in a research note on Wednesday, October 10th. Baader Bank set a €65.00 ($75.58) price objective on shares of Lanxess and gave the company a sell rating in a research note on Friday, September 21st. Finally, Credit Suisse Group set a €65.00 ($75.58) price objective on shares of Lanxess and gave the company a neutral rating in a research note on Tuesday, November 13th. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and ten have given a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus price target of €64.25 ($74.71).
ETR:LXS traded down €0.69 ($0.80) during midday trading on Thursday, hitting €45.69 ($53.13). The company had a trading volume of 458,744 shares, compared to its average volume of 312,027. Lanxess has a 52-week low of €59.89 ($69.64) and a 52-week high of €74.50 ($86.63).
LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.
Recommended Story: Cost of Equity For A Business, Investors
Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.